4-Hydroxyisoleucine inhibits tumor growth by triggering endoplasmic reticulum stress and autophagy
Authors:
Open Access
- 9 September 2022
- journal article
- research article
- Published by Elsevier in Current Research in Pharmacology and Drug Discovery
- Vol. 3, 100127
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (1522300410028)
This publication has 34 references indexed in Scilit:
- Autophagy and Cellular Immune ResponsesImmunity, 2013
- Deconvoluting the context-dependent role for autophagy in cancerNature Reviews Cancer, 2012
- A novel l-isoleucine metabolism in Bacillus thuringiensis generating (2S,3R,4S)-4-hydroxyisoleucine, a potential insulinotropic and anti-obesity amino acidApplied Microbiology and Biotechnology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- 3D tomography reveals connections between the phagophore and endoplasmic reticulumAutophagy, 2009
- Does autophagy have a license to kill mammalian cells?Cell Death & Differentiation, 2008
- Adaptation to ER Stress Is Mediated by Differential Stabilities of Pro-Survival and Pro-Apoptotic mRNAs and ProteinsPLOS Biology, 2006
- Mediators of endoplasmic reticulum stress‐induced apoptosisEMBO Reports, 2006
- Regulation and role of autophagy in mammalian cellsThe International Journal of Biochemistry & Cell Biology, 2004
- Quality control in the endoplasmic reticulum protein factoryNature, 2003